Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: NPT, LIC

University Lab Partners Selected to Lead the Next Generation of the BARDA Accelerator Network as the Medical Devices and Diagnostics Hub


IRVINE, Calif., May 6, 2024 /PRNewswire/ -- University Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the BARDA Accelerator Network of the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

Partnership highlights dedication to life science innovation, leveraging Orange County's medical device sector strength.

The next generation of the BARDA Accelerator Network builds on lessons learned from the first iteration of the Network and from the COVID-19 pandemic regarding the importance of agile and scalable mechanisms to support innovation. This network will be comprised of at least five hubs across the U.S. that will focus on supporting innovations in: Diagnostics/Medical Devices, Therapeutics/Vaccines, Digital Health Tools, Special Populations, and Enabling Technologies.  Together, these five hubs will enable BARDA to foster the growth of the innovation ecosystem and partner with entrepreneurs, innovators, and companies to develop adaptable, scalable, sustainable, accessible, and equitable health security solutions.

"We are looking forward to this partnership with BARDA and the opportunity to collaborate with the other hubs as a key partner in the next generation of the BARDA Accelerator Network," said Karin Koch, Executive Director of University Lab Partners. "This partnership highlights our dedication to driving innovation in the life sciences and leverages Orange County's strength in the medical device sector, ultimately contributing to the enhancement of national health security preparedness."

ULP is partnering with the Consortium for Improving Medicine with Innovation & Technology (CIMIT) at the Massachusetts General Hospital and Harvard Medical School and Science Exchange to establish the International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE). This hub will focus on developing diagnostics and devices to detect, prevent, or respond to medical consequences that result from health security threats.

Additionally, VITAL, a global accelerator based in Cambridge, MA, with innovation hubs in the U.S., Asia, Europe, and South America, in collaboration with Advise Connect Inspire (ACI) and BioInnovation Labs (BioLabs), will form the VITAL (Vaccine Innovation and Therapeutics Acceleration Launchpad) hub to support therapeutics and vaccines innovation.  

The BARDA Accelerator Network aims to provide comprehensive support to health security innovators, startups, and BARDA portfolio companies through wrap-around accelerator services, technical and business/commercialization expertise, and resources. The network will facilitate the rapid development, evaluation, validation, and commercialization of medical countermeasures.

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00007.

To learn more, visit www.universitylabpartners.org/BARDA

About University Lab Partners

University Lab Partners (ULP) is a premier nonprofit wet lab incubator located in Orange County, CA. Operating two facilities in Irvine and Aliso Viejo, ULP offers highly equipped wet lab facilities along with the benefits of peer-to-peer interactions and accelerator services among a life science-focused entrepreneurial community. For more information, visit www.universitylabpartners.org.

SOURCE University Lab Partners


These press releases may also interest you

at 07:13
Webblogic®, a pioneer in medical device manufacturing technology, is set to launch its comprehensive range of advanced manufacturing and packaging equipment specifically designed for the Medical Device, Pharma, and Life Sciences industries. In...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...



News published on and distributed by: